What Happened:

Shares of 3D printing company 3D Systems (NYSE:DDD) jumped 9.2% in the afternoon session after the company announced it received FDA approval for its jetted dentures solution, which uses its jetting technology to create durable, aesthetically pleasing dentures. The FDA approval should provide a clearer path to commercialization and signal to investors that the company can monetize the product. 

Notably, the company is partnering with Glidewell, one of the largest dental laboratories, as part of its market penetration efforts. Also, the global 3D printed dentures market is expected to reach $2 billion by 2028 (using estimates from 360 Market Updates), and the announcement suggests 3D Systems is well-positioned to capture market share.

Is now the time to buy 3D Systems? Access our full analysis report here, it’s free.

What is the market telling us:

3D Systems’s shares are very volatile and over the last year have had 65 moves greater than 5%. In context of that, today’s move is indicating the market considers this news meaningful but not something that would fundamentally change its perception of the business.

3D Systems is down 57.7% since the beginning of the year, and at $2.60 per share it is trading 61.7% below its 52-week high of $6.79 from December 2023. Investors who bought $1,000 worth of 3D Systems’s shares 5 years ago would now be looking at an investment worth $300.58.

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.